Expression of CD44v6 Correlates with Cell Proliferation and Cellular Atypia in Urothelial Carcinoma Cell Lines 5637 and HT1197 Cited by

Fol. Biol. 2005, 51, 3-11

https://doi.org/10.14712/fb2005051010003

Expression of CD44v6 Correlates with Cell Proliferation and Cellular Atypia in Urothelial Carcinoma Cell Lines 5637 and HT1197

J. Kuncová¹, Z. Kostrouch², M. Viale³, R. Revoltella⁴, Václav Mandys⁵

¹Clinical Department of Urology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
²Institute of Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
³National Cancer Research Institute, Pharmacotoxicology Unit, Genova, Italy
⁴Institute of Biomedical Technologies, Immunobiology and Cell Differentiation Unit, CNR, Pisa, Italy
⁵Department of Pathology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic

Received November 2004
Accepted December 2004

Crossref Cited-by Linking

Li Heng, Yu Gan, Shi Runlin, Lang Bin, Chen Xianguo, Xia Ding, Xiao Haibing, Guo Xiaolin, Guan Wei, Ye Zhangqun, Xiao Wei, Xu Hua: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Mol Cancer 2014, 13. <https://doi.org/10.1186/1476-4598-13-8>
van der Horst Geertje, Bos Lieke, van der Pluijm Gabri: Epithelial Plasticity, Cancer Stem Cells, and the Tumor-Supportive Stroma in Bladder Carcinoma. Molecular Cancer Research 2012, 10, 995. <https://doi.org/10.1158/1541-7786.MCR-12-0274>
Omran Ola M., Ata Hesham S.: CD44s and CD44v6 in Diagnosis and Prognosis of Human Bladder Cancer. Ultrastructural Pathology 2012, 36, 145. <https://doi.org/10.3109/01913123.2011.651522>
Langeveld Danielle, Jansen Marnix, Brosens Lodewijk, Morsink Folkert, Offerhaus G. Johan, de Leng Wendy: Diversity Counts. American Journal of Clinical Pathology 2011, 135, 878. <https://doi.org/10.1309/AJCPP3I5HDYWMHJA>